Brand-name Ozempic, Wegovy, and Zepbound carry significant monthly costs, often $900 to over $1,000 out of pocket without insurance coverage
Using it solely for weight lossparticularly in people without diabetesmay expose patients to adverse effects **without** the robust weight outcomes seen with dedicated therapies
As obesity drug development expands beyond injectable GLP-1s, companies are advancing oral pills, dual and triple agonists, amylin-based candidates and metabolic disease programs
Karagiannis T, Tsapas A, Athanasiadou E, et al
Major food manufacturers are seeking to dismiss one of the first lawsuits to link ultra-processed foods (UPFs) to chronic health problems in children, following a complaint filed by a Pennsylvania man who developed type 2 diabetes and fatty liver disease during his teenage years
This process is mediated by a complex reflex involving a swallowing centre in the dorsal motor nucleus of the vagus in the brainstem